Original Release on February 6th, 2023: As new gene therapies are researched, developed and begin clinical trials, what hurdles must genetic medicine overcome before these therapies are commonly available? Head of U.S. Pharmaceuticals Terence Flynn and Head of U.S. Biotech Matthew Harrison discuss.
Jan 2019
a16z Podcast: The Science and Business of Innovative Medicines
<p>with Vas Narasimhan (@vasnarasimhan), Jorge Conde (@jorgecondebio), Vijay Pande (@vijaypande), and Sonal Chokshi (@smc90)</p><p>On average, only 1 out of 20 medicines works when we actually bring them into the human body, and these rates of success haven't moved much in the ph ... Show More
59m 2s
Sep 2023
The fact that you can change the shape of the curve of life, like really bend the curve of life is amazing.
You're basically creating miracles that fit in the palm of your hand and you're helping reimagine life for patients.20 YEARS IN PERSPECTIVE:Givers are not good takers.I don't think of the 2000s as twenty years ago, I still think of the 80s, or the 70s as twenty years ago.I starte ... Show More
40m 31s
Aug 2023
How Oncologists Are Confronting the Cancer Drug Shortage
<p><span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">Drs. Vamsi Velcheti, Taofeek Owonikoko, and Janakiraman Subramanian discuss their experiences navigating the cancer drug shortage in the United States, the impact on patients and clinical trial enrollme ... Show More
25m 17s